Depreciation of ORAMED PHARMACEUTICALS INC. from 30 Nov 2010 to 31 Mar 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
ORAMED PHARMACEUTICALS INC. quarterly and annual Depreciation in USD history and change rate from 30 Nov 2010 to 31 Mar 2025.
  • ORAMED PHARMACEUTICALS INC. Depreciation for the quarter ending 31 Mar 2025 was $30,000, a 46% decline year-over-year.
  • ORAMED PHARMACEUTICALS INC. annual Depreciation for 2024 was $193,000, a 1.5% decline from 2023.
  • ORAMED PHARMACEUTICALS INC. annual Depreciation for 2023 was $196,000, a 238% increase from 2022.
  • ORAMED PHARMACEUTICALS INC. annual Depreciation for 2022 was $58,000, a 25% decline from 2021.
Source SEC data
View on sec.gov
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)

ORAMED PHARMACEUTICALS INC. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $30,000 -$26,000 -46% 01 Jan 2025 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q1 2024 $56,000 +$19,000 +51% 01 Jan 2024 31 Mar 2024 10-Q 15 May 2025 2025 Q1
Q1 2023 $37,000 +$26,000 +236% 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024 2024 Q1
Q1 2022 $11,000 -$17,000 -61% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023 2023 Q1
Q4 2021 $18,000 +$11,000 +157% 01 Sep 2021 31 Dec 2021 10-K 06 Mar 2023 2022 FY
Q1 2021 $28,000 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022 2022 Q1
Q4 2020 $7,000 01 Sep 2020 31 Dec 2020 10-QT 30 Mar 2022 2021 Q2
Q4 2018 $2,000 +$1,000 +100% 01 Sep 2018 30 Nov 2018 10-Q 09 Jan 2020 2020 Q1
Q4 2017 $1,000 $0 0% 01 Sep 2017 30 Nov 2017 10-Q 14 Jan 2019 2019 Q1
Q4 2016 $1,000 $0 0% 01 Sep 2016 30 Nov 2016 10-Q 11 Jan 2018 2018 Q1
Q4 2015 $1,000 01 Sep 2015 30 Nov 2015 10-Q 11 Jan 2017 2017 Q1
Q4 2013 $1,871 -$400 -18% 01 Sep 2013 30 Nov 2013 10-Q 14 Jan 2014 2014 Q1
Q4 2012 $2,271 -$3,771 -62% 01 Sep 2012 30 Nov 2012 10-Q 14 Jan 2014 2014 Q1
Q4 2011 $6,042 -$1,409 -19% 01 Sep 2011 30 Nov 2011 10-Q 26 Dec 2012 2013 Q1
Q4 2010 $7,451 01 Sep 2010 30 Nov 2010 10-Q 12 Jan 2012 2012 Q1

ORAMED PHARMACEUTICALS INC. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $193,000 -$3,000 -1.5% 01 Jan 2024 31 Dec 2024 10-K 27 Mar 2025 2024 FY
2023 $196,000 +$138,000 +238% 01 Jan 2023 31 Dec 2023 10-K 27 Mar 2025 2024 FY
2022 $58,000 -$19,000 -25% 01 Jan 2022 31 Dec 2022 10-K 06 Mar 2024 2023 FY
2021 $77,000 +$70,000 +1000% 01 Sep 2020 31 Aug 2021 10-K 06 Mar 2023 2022 FY
2020 $7,000 -$1,000 -12% 01 Sep 2019 31 Aug 2020 10-K 24 Nov 2021 2021 FY
2019 $8,000 +$2,000 +33% 01 Sep 2018 31 Aug 2019 10-K 24 Nov 2020 2020 FY
2018 $6,000 +$1,000 +20% 01 Sep 2017 31 Aug 2018 10-K 27 Nov 2019 2019 FY
2017 $5,000 +$1,000 +25% 01 Sep 2016 31 Aug 2017 10-K 27 Nov 2019 2019 FY
2016 $4,000 $0 0% 01 Sep 2015 31 Aug 2016 10-K 28 Nov 2018 2018 FY
2015 $4,000 -$2,000 -33% 01 Sep 2014 31 Aug 2015 10-K 29 Nov 2017 2017 FY
2014 $6,000 +$1,000 +20% 01 Sep 2013 31 Aug 2014 10-K 25 Nov 2016 2016 FY
2013 $5,000 -$10,000 -67% 01 Sep 2012 31 Aug 2013 10-K 25 Nov 2015 2015 FY
2012 $15,000 -$13,303 -47% 01 Sep 2011 31 Aug 2012 10-K 14 Nov 2014 2014 FY
2011 $28,303 01 Sep 2010 31 Aug 2011 10-K 12 Dec 2012 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.